PEBP1 and chromophobe renal cell carcinoma: For example, studies in clear cell kidney cancer (cRCC) have shown that circPOLR2A can downregulate the protein level of recombinant phosphatidylethanolamine binding protein 1 (PEBP1), thereby activating the ERK signaling pathway.